Skip to content
AnalystLens

International Flavors & Fragrances 8-K Report, Executive Changes (Jul 30, 2025)

Reports
Leadership Changes
Filing Date
Filed July 30, 2025
Period End
July 29, 2025
Security
IFF
In the record · 2016–202610-K1110-Q338-K151

IFF filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 151 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Oct ’18Oct ’18
  2. Deal closed8-K · Feb ’21Feb ’21
  3. Leadership change8-K · Feb ’23Feb ’23
  4. Leadership change8-K · Nov ’26Nov ’26

Summary

Summary of the 8-K filed July 30, 2025. Cited figures are marked; the original filing is the authoritative source.

International Flavors & Fragrances Inc. (the Company) announced on July 29, 2025 that Jesus Mantas and Paul Fribourg were appointed to its Board of Directors, effective July 29, 2025.

Mr. Mantas was named to the Board's Audit Committee and Innovation Committee, and Mr. Fribourg was named to the Board's Transaction Committee. The filing states that the Board has determined both directors are independent under New York Stock Exchange rules and the Company's own independence requirements. Mr. Mantas, 56, is a former Global Managing Partner at IBM Consulting, where he led the $10Ba Business Transformation Services unit and held several other senior leadership roles, and he currently chairs the Compensation and Management Development Committee of Biogen Inc.'s board.

Mr. Fribourg, 71, is Chairman and Chief Executive Officer of Continental Grain Company, a position he has held since 1976, and he serves on the boards of Loews Corp., The Estée Lauder Companies Inc., Syngenta Group Co. Ltd. and Wayne-Sanderson Farms LLC. The filing states there is no arrangement or understanding under which either director was appointed, and no related-person transaction above $120,000b in which either had a material interest since the beginning of the last fiscal year. Both directors will participate in the non-employee director compensation arrangements described in the Company's 2024 Proxy Statement, filed March 18, 2025.

Key Highlights

  1. Jesus Mantas and Paul Fribourg were appointed to the IFF Board of Directors, effective July 29, 2025.
  2. Mr. Mantas joins the Audit Committee and Innovation Committee; Mr. Fribourg joins the Transaction Committee.
  3. Mr. Mantas, 56, is a former Global Managing Partner at IBM Consulting and currently chairs the Compensation and Management Development Committee at Biogen Inc.
  4. Mr. Fribourg, 71, has been Chairman and CEO of Continental Grain Company since 1976 and serves on several public company boards, including The Estée Lauder Companies Inc.
  5. The Board determined both new directors are independent under NYSE rules and the Company's independence requirements.
  6. Both directors will receive non-employee director compensation under arrangements described in the 2024 Proxy Statement filed March 18, 2025.
  7. The filing reports no related-person transactions above $120,000 involving either director and no arrangement under which either was selected for the Board.

Frequently Asked Questions

  1. Who were appointed to the IFF Board of Directors?

    Jesus Mantas and Paul Fribourg were appointed to the Board, effective July 29, 2025.

  2. What committee roles were assigned to the new directors?

    Mr. Mantas was named to the Audit Committee and Innovation Committee. Mr. Fribourg was named to the Transaction Committee.

  3. Are the new directors considered independent?

    Yes. The Board has determined that both Mr. Mantas and Mr. Fribourg qualify as independent directors under New York Stock Exchange rules and the Company's Board independence requirements.

  4. What is the professional background of the new directors?

    Mr. Mantas, 56, previously served as Global Managing Partner leading the $10B Business Transformation Services unit at IBM Consulting and currently chairs the Compensation and Management Development Committee of Biogen Inc.'s Board. Mr. Fribourg, 71, has served as Chairman and CEO of Continental Grain Company since 1976 and serves on the boards of Loews Corp., The Estée Lauder Companies Inc., Syngenta Group Co. Ltd. and Wayne-Sanderson Farms LLC.

  5. How will the new directors be compensated?

    Both directors will participate in the non-employee director compensation arrangements described in the Company's 2024 Proxy Statement, which was filed with the SEC on March 18, 2025.